Vitamin C, E Pills Fail to Prevent Cancer
Study Shows No Sign of Lower Cancer Risk in People Taking Vitamin E and Vitamin C Supplements
Nov. 17, 2008 -- Taking vitamin E and vitamin C supplements may not make cancer less likely, a new study shows.
That finding comes from the Physicians' Health Study II, which recently showed that taking vitamin C and vitamin E supplements may not lower the risk of heart attack or stroke.
Researchers have now analyzed study data on cancer risk and found no sign of lower cancer risk in people taking vitamin E and vitamin C supplements daily during the study.
Here's a look at the study, which was presented yesterday in Washington, D.C., at an international meeting on cancer prevention research hosted by the American Association for Cancer Research (AACR).
The study included some 14,600 male doctors aged 50 and older in the U.S.
Some of the doctors were assigned to take 400 international units (IU) of vitamin E every other day. Others were assigned to take 500 milligrams of vitamin C every day during the study. For comparison, a third group of doctors got placebo pills.
Among all the doctors, there were 1,929 cases of cancer, including 1,013 cases of prostate cancer, during the study. Cancer rates were similar among the doctors taking vitamin E or vitamin C supplements and those taking the placebo.
"After nearly 10 years of supplementation with either vitamin E or vitamin C, we found no evidence supporting the use of either supplement in the prevention of cancer," Howard Sesso, ScD, MPH, says in an AACR news release.
Sesso, who is an assistant professor of medicine at Brigham and Women's Hospital in Boston, adds that there was also no sign that either supplement was harmful.
The findings are only about vitamin E and vitamin C from supplements, not foods.
"Individual vitamin supplements such as vitamin E and C do not appear to provide the same potential advantages as vitamins included as part of a healthy, balanced diet," J. Michael Gaziano, MD, MPH, says in the AACR news release. Gaziano, an associate professor of medicine at Brigham and Women's Hospital, worked with Sesso on the study.